Clinical trial on effectiveness of Varmam therapy for Otrai thalai vali ( Migraine )

Phase 3

Conditions: Health Condition 1: G439- Migraine, unspecified

Registration Number: CTRI/2023/09/057265

Lead Sponsor: ational Institute of Siddha

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

History of five attacks lasting for 4-72 hours in the past 3 months

Patients having the symptoms of unilateral headache with pulsating quality, pain with mild to moderate intensity and aggravated by routine physical activity

Patients must have any one of the following symptoms,

Often accompanied by nausea (and/or vomiting)

Photophobia

Phonophobia

Patient who are willing to involve in the study by signing the consent and fulfilling the condition of performa

Patient who has Headache Impact Test total score 36-59 and Migraine Disability Assessment Test score 6-20

Exclusion Criteria

K/C/O Cardiovascular disease.

K/C/O Trigeminal neuralgia

K/C/O Trauma

Patients with uncontrolled diabetes mellitus

Patients with uncontrolled hypertension

K/C/O Psychiatric diseases

K/C/O of Seizures

K/C/O Eye disease and uncorrected refractive errors

K/C/O cervical spondylosis

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Outcome of the study is mainly assessed by reduction in clinical symptoms through, <br/ ><br>Headache Impact Test Scale <br/ ><br>Migraine Disability Assessment Test Scale <br/ ><br>Headache diary. <br/ ><br>Timepoint: The outcome is measured 2 weeks once <br/ ><br>

Secondary Outcome Measures